Seastar Medical Holding CORP DEF 14A proxy statements

SeaStar Medical Holding Corporation is seeking stockholder approval for a 1-for-10 reverse stock split and a reduction in authorized common shares to maintain Nasdaq listing and support future growth.

SeaStar Medical is holding its 2025 Annual Meeting of Stockholders virtually on July 3, 2025, to vote on key proposals including director elections, equity incentive plan amendments, and a potential stock issuance to Lincoln Park Capital Fund, LLC.

SeaStar Medical Holding Corporation will hold its annual meeting of stockholders on July 3, 2025, to vote on key proposals including the election of directors, an amendment to the equity incentive plan, approval of potential stock sales to Lincoln Park Capital Fund, and ratification of the company's accounting firm.

SeaStar Medical Holding Corporation amends its proxy statement to clarify the number of outstanding shares as of January 31, 2025, before its Special Meeting of Stockholders.

SeaStar Medical Holding Corporation is holding a special meeting on March 20, 2025, to seek stockholder approval for the issuance of common warrants and the extension of the term of Series B warrants to comply with Nasdaq listing rules.

SeaStar Medical is holding a special meeting to ratify prior share issuances to maintain its Nasdaq listing and to approve a reduction in the number of authorized shares of common stock.

SeaStar Medical Holding Corporation will hold its 2024 Annual Meeting of Stockholders virtually on June 4, 2024, to vote on director elections, an equity incentive plan amendment, a Nasdaq proposal, and auditor ratification.